Arne Mørk

5.2k total citations
93 papers, 4.0k citations indexed

About

Arne Mørk is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Arne Mørk has authored 93 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Cellular and Molecular Neuroscience, 40 papers in Molecular Biology and 22 papers in Pharmacology. Recurrent topics in Arne Mørk's work include Neuroscience and Neuropharmacology Research (44 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Receptor Mechanisms and Signaling (19 papers). Arne Mørk is often cited by papers focused on Neuroscience and Neuropharmacology Research (44 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Receptor Mechanisms and Signaling (19 papers). Arne Mørk collaborates with scholars based in Denmark, United States and Netherlands. Arne Mørk's co-authors include Jacob P. R. Jacobsen, Arne Geisler, Connie Sánchez, Sandra Hogg, Tine B. Stensbøl, Christoffer Bundgaard, Liliana P. Montezinho, A. Geisler, Benny Bang‐Andersen and Mads Kreilgaard and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Biological Psychiatry.

In The Last Decade

Arne Mørk

90 papers receiving 3.9k citations

Peers

Countries citing papers authored by Arne Mørk

Since Specialization

Citations

This map shows the geographic impact of Arne Mørk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Mørk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Mørk more than expected).

Fields of papers citing papers by Arne Mørk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Mørk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Mørk. The network helps show where Arne Mørk may publish in the future.

Co-authorship network of co-authors of Arne Mørk

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Mørk. A scholar is included among the top collaborators of Arne Mørk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Mørk. Arne Mørk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter 2020 ·Nature Communications ·Per Plenge, Ara M. Abramyan, G. Sørensen, Arne Mørk, Pia Weikop, Ulrik Gether, Benny Bang‐Andersen, Lei Shi, Claus J. Løland	36
2	A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission 2017 ·Translational Psychiatry ·Jacob Nielsen, Kim Fejgin, Florence Sotty, Vibeke Nielsen, Arne Mørk, Claus T. Christoffersen, Leonid Yavich, (unknown), (unknown), Peter H. Larsen, Jan Egebjerg, Thomas Werge, Pekka Kallunki, Kenneth Vielsted Christensen, Michael Didriksen	34
3	Pharmacokinetic/Pharmacodynamic Relationship of Gabapentin in a CFA-induced Inflammatory Hyperalgesia Rat Model 2016 ·Pharmaceutical Research ·(unknown), Ron J. Keizer, Gordon Munro, Arne Mørk, René Holm, Rada Savic, Mads Kreilgaard	12
4	The Schizophrenia-Associated BRD1 Gene Regulates Behavior, Neurotransmission, and Expression of Schizophrenia Risk Enriched Gene Sets in Mice 2016 ·Biological Psychiatry ·Per Qvist, Jane Christensen, Irina Vardya, Anto P. Rajkumar, Arne Mørk, (unknown), Ernst‐Martin Füchtbauer, Jonatan Pallesen, (unknown), (unknown), Mads E. Hauberg, (unknown), Kim Fejgin, Mette Nyegaard, Kimmo Jensen, Jens Randel Nyengaard, Ole Mors, Michael Didriksen, Anders D. Børglum	19
5	The 5-HT6 receptor antagonist idalopirdine potentiates the effects of acetylcholinesterase inhibition on neuronal network oscillations and extracellular acetylcholine levels in the rat dorsal hippocampus 2016 ·Neuropharmacology ·Kjartan F. Herrik, Arne Mørk, (unknown), Christoffer Bundgaard, Jesper F. Bastlund, Inge E.M. de Jong	32
6	Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats 2013 ·Pharmacology Biochemistry and Behavior ·Arne Mørk, Liliana P. Montezinho, Silke Miller, (unknown), Niels Plath, Yan Li, Maria Gulinello, Connie Sánchez	124
7	Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder 2011 ·Journal of Medicinal Chemistry ·Benny Bang‐Andersen, Thomas Ruhland, Morten Jørgensen, Garrick P. Smith, Kristen Frederiksen, Klaus Gjervig Jensen, Huailing Zhong, Søren Nielsen, Sandra Hogg, Arne Mørk, Tine B. Stensbøl	355
8	Involvement of a Subpopulation of Neuronal M₄Muscarinic Acetylcholine Receptors in the Antipsychotic-like Effects of the M₁/M₄Preferring Muscarinic Receptor Agonist Xanomeline 2011 ·Journal of Neuroscience ·Ditte Dencker, Gitta Wörtwein, Pia Weikop, Jongrye Jeon, Morgane Thomsen, Thomas N. Sager, Arne Mørk, David P.D. Woldbye, Jürgen Wess, Anders Fink‐Jensen	49
9	HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells 2010 ·Journal of Neurochemistry ·Jens Leander Johansen, Thomas Nikolaj Sager, Julie Lotharius, Louise Witten, Arne Mørk, Jan Egebjerg, Kenneth Thirstrup	42
10	Differential effects of γ‐secretase and BACE1 inhibition on brain Aβ levels in vitro and in vivo 2009 ·Journal of Neurochemistry ·(unknown), Christiane Volbracht, Lars Østergaard Pedersen, Klaus Gjervig Jensen, (unknown), (unknown), Arne Mørk, Tine B. Stensbøl, Jesper F. Bastlund	21
11	Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice 2009 ·Neuroreport ·(unknown), Arne Mørk, Lise T. Brennum, Thomas N. Sager	9
12	Nest building performance following MPTP toxicity in mice 2009 ·Behavioural Brain Research ·Thomas Nikolaj Sager, (unknown), Arne Mørk, Johan van Beek, Kenneth Thirstrup, Michael Didriksen, (unknown)	40
13	Augmentation of SSRI Effects on Serotonin by 5-HT2C Antagonists: Mechanistic Studies 2007 ·Neuropsychopharmacology ·Thomas I.F.H. Cremers, Kieran Rea, Fokko J. Bosker, Håkan Wikström, Sandra Hogg, Arne Mørk, Ben H.C. Westerink	60
14	Pharmacokinetic/Pharmacodynamic Feedback Modelling of the Functional Corticosterone Response in Rats after Acute Treatment with Escitalopram 2007 ·Basic & Clinical Pharmacology & Toxicology ·Christoffer Bundgaard, (unknown), Martin Grønbech Jørgensen, Arne Mørk	8
15	Monoaminergic dysregulation in glutathione-deficient mice: Possible relevance to schizophrenia? 2005 ·Neuroscience ·Jacob P. R. Jacobsen, Ramona M. Rodriguiz, Arne Mørk, William C. Wetsel	28
16	Abnormal protein phosphorylation in post-mortem brain tissue from bipolar patients 2000 ·Journal of Neural Transmission ·(unknown), Hady Shimon, Arne Mørk	6
17	Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram 2000 ·European Journal of Pharmacology ·Thomas I.F.H. Cremers, (unknown), Peter de Boer, Fokko J. Bosker, Arne Mørk, Johan A. den Boer, Ben H.C. Westerink, Håkan Wikström	41
18	Effects of lithium treatment on extracellular serotonin levels in the dorsal hippocampus and wet-dog shakes in the rat 1998 ·European Neuropsychopharmacology ·Arne Mørk	12
19	Effects of Chronic Lithium Treatment on Agonist‐Enhanced Extracellular Concentrations of Cyclic AMP in the Dorsal Hippocampus of Freely Moving Rats 1995 ·Journal of Neurochemistry ·Arne Mørk, Arne Geisler	30
20	The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms 1989 ·Neuropharmacology ·Arne Mørk, A. Geisler	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact